Researchers at the New York University School of Medicine and the Instituto de Neurociencias de Alicante (Institute of Neuroscience in Alicante, Spain) conducted a study on CBD to determine whether cannabidiol, or CBD, would be an effective treatment for anxiety-related disorders. Their study was published in the Neurotheraputics journal.
By assessing evidence from preclinical, human experimental, clinical and epidemiological studies, the researchers determined that preclinical evidence strongly supports CBD as a treatment for generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive-compulsive disorder and post-traumatic stress disorder, when administered acutely.
Few studies, however, have investigated chronic CBD dosing, especially in clinical populations. The study concluded that while current evidence indicates that CBD has considerable potential as a treatment for multiple anxiety disorders, the need for further study of chronic and therapeutic effects in relevant clinical populations is necessary.
To read the full research paper, click here